The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Jun. 29, 2021
Applicant:
Mexichem Fluor S.a. DE C.v., San Luis Potosi S.L.P., MX;
Inventors:
Stuart Corr, Cheshire, GB;
Timothy James Noakes, Flintshire, GB;
Assignee:
MEXICHEM FLUOR S.A. DE C.V., San Luis Potosi S.L.P., MX;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/40 (2006.01); A61K 47/58 (2017.01); A61P 11/00 (2006.01); A61K 9/00 (2006.01); A61K 31/4704 (2006.01); A61K 31/573 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 45/06 (2006.01); A61K 31/56 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/40 (2013.01); A61K 9/008 (2013.01); A61K 31/4704 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/24 (2013.01); A61K 47/32 (2013.01); A61K 47/58 (2017.08); A61P 11/00 (2018.01);
Abstract
A pharmaceutical composition is described. The composition may include a drug component and a propellant component. The drug component comprises at least one pharmaceutically acceptable salt of glycopyrrolate, beclomethasone diproprionate, and at least one long acting beta-2-agonist (LABA) selected from formoterol and the pharmaceutically acceptable salts thereof. The propellant component comprises 1,1-difluoroethane (HFA-152a).